Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Phase 2 Completed 10 enrolled University of Aarhus

RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effect of subcutaneous administration of immunoglobulin compared to intravenous treatment, for multifocal motor neuropathy NB. ONLY RECRUITING FROM DENMARK

Timeline

Start: 2005-08
Primary completion: 2008-02
Completion: 2008-02

Publications

Harbo T, Andersen H, Hess A, Hansen K, Sindrup SH, Jakobsen J. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol. 2009 May;16(5):631-8. doi: 10.1111/j.1468-1331.2009.02568.x. Epub 2009 Feb 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Immune Globulin Intravenous (Human)	Protein / enzyme biologic	—	Subcutaneous
Comparator	Immune Globulin Intravenous (Human)	Protein / enzyme biologic	—	Intravenous

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Summary

Timeline

Publications

Drugs

Indications